161 related articles for article (PubMed ID: 37559977)
1. Risk, molecular subtype and prognosis of second primary breast cancer: an analysis based on first primary cancers.
Li C; Du C; Wang Y; Liu M; Zhao F; Li J; Wang W; Wei X; Qu J; Zhou Z; Zhang Y; Zhang S
Am J Cancer Res; 2023; 13(7):3203-3220. PubMed ID: 37559977
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study.
Lee EG; Lim J; Ha HI; Lim MC; Chang YJ; Won YJ; Jung SY
Front Oncol; 2023; 13():1208320. PubMed ID: 37781206
[TBL] [Abstract][Full Text] [Related]
3. Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
Cheng Y; Huang Z; Liao Q; Yu X; Jiang H; He Y; Yao S; Nie S; Liu L
PLoS One; 2020; 15(6):e0232800. PubMed ID: 32497148
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Factors Affecting Survival of Patients With Single Primary Breast Cancer vs Patients With Multiple Primary Cancers in Lifetime, One of Which is Breast Cancer.
Sanli AN; Tekcan Sanli DE; Altundag MK; Aydogan F
Am Surg; 2024 Apr; ():31348241248695. PubMed ID: 38676386
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and survival of second primary breast carcinoma with extramammary malignancies.
Jing Y; Wang X; Sun B
Front Oncol; 2023; 13():1160370. PubMed ID: 37007094
[TBL] [Abstract][Full Text] [Related]
6. Relationship between metastasis and second primary cancers in women with breast cancer.
Li C; Liu M; Li J; Zhao X; Wang Y; Chen X; Wang W; Sun S; Feng C; Cai Y; Wu F; Du C; Zhang Y; Zhang S; Qu J
Front Oncol; 2022; 12():942320. PubMed ID: 36248962
[TBL] [Abstract][Full Text] [Related]
7. Second Primary Breast Cancer in Young Breast Cancer Survivors.
Brantley KD; Rosenberg SM; Collins LC; Ruddy KJ; Tamimi RM; Schapira L; Borges VF; Warner E; Come SE; Zheng Y; Kirkner GJ; Snow C; Winer EP; Partridge AH
JAMA Oncol; 2024 Jun; 10(6):718-725. PubMed ID: 38602683
[TBL] [Abstract][Full Text] [Related]
8. The changes of subtype markers between first and second primary breast cancers.
Li C; Lyu Z; Wang Z; Hao C; Huang Y; Song F
Cancer Med; 2023 Jun; 12(12):13649-13660. PubMed ID: 37096879
[TBL] [Abstract][Full Text] [Related]
9. Tumor marker phenotype concordance in second primary breast cancer, California, 1999-2004.
Brown M; Bauer K; Pare M
Breast Cancer Res Treat; 2010 Feb; 120(1):217-27. PubMed ID: 19629680
[TBL] [Abstract][Full Text] [Related]
10. Association of First Primary Cancer With Risk of Subsequent Primary Cancer Among Survivors of Adult-Onset Cancers in the United States.
Sung H; Hyun N; Leach CR; Yabroff KR; Jemal A
JAMA; 2020 Dec; 324(24):2521-2535. PubMed ID: 33351041
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Occult Breast Cancer Patients.
Qu J; Li C; Liu M; Wang Y; Feng Z; Li J; Wang W; Wu F; Zhang S; Zhao X
J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176539
[TBL] [Abstract][Full Text] [Related]
12. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.
Press DJ; Miller ME; Liederbach E; Yao K; Huo D
Clin Exp Metastasis; 2017 Dec; 34(8):457-465. PubMed ID: 29288366
[TBL] [Abstract][Full Text] [Related]
13. Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort.
Ramin C; Veiga LHS; Vo JB; Curtis RE; Bodelon C; Aiello Bowles EJ; Buist DSM; Weinmann S; Feigelson HS; Gierach GL; Berrington de Gonzalez A
Breast Cancer Res; 2023 May; 25(1):50. PubMed ID: 37138341
[TBL] [Abstract][Full Text] [Related]
14. Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status.
Sung H; Freedman RA; Siegel RL; Hyun N; DeSantis CE; Ruddy KJ; Jemal A
Cancer; 2021 Sep; 127(18):3310-3324. PubMed ID: 34002851
[TBL] [Abstract][Full Text] [Related]
15. Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer.
Chen XS; Ma CD; Wu JY; Yang WT; Lu HF; Wu J; Lu JS; Shao ZM; Shen ZZ; Shen KW
Tumori; 2010; 96(1):103-10. PubMed ID: 20437866
[TBL] [Abstract][Full Text] [Related]
16. Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort Study.
Chen F; Park SL; Wilkens LR; Wan P; Hart SN; Hu C; Yadav S; Couch FJ; Conti DV; de Smith AJ; Haiman CA
Cancer Res; 2022 Sep; 82(18):3201-3208. PubMed ID: 35834270
[TBL] [Abstract][Full Text] [Related]
17. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
18. The Prognosis of Single Hormone Receptor-Positive Breast Cancer Stratified by HER2 Status.
Zhao H; Gong Y
Front Oncol; 2021; 11():643956. PubMed ID: 34079755
[TBL] [Abstract][Full Text] [Related]
19. Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer.
Xiao Y; Zhang S; Hou G; Zhang X; Hao X; Zhang J
Tumour Biol; 2014 Mar; 35(3):2035-45. PubMed ID: 24096546
[TBL] [Abstract][Full Text] [Related]
20. Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.
Guan D; Jie Q; Wu Y; Xu Y; Hong W; Meng X
World J Surg Oncol; 2022 Sep; 20(1):326. PubMed ID: 36175898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
